Please assess the completion status of the following clinical trial:

Trial Title: Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients over 18 years of age~* Patients presenting with a lung or pleural nodule or mass presumed to be resectable on pre-operative assessment~* Good operative candidate~* Subject capable of giving informed consent and participating in the process of consent~Exclusion Criteria:~* Pregnant women as determined by urinary or serum beta human chorionic gonadotropin (hCG) within 72 hours of surgery~* Patients with a history of anaphylactic reactions to Folate-FITC or insects~* At-risk patient populations:~  * Homeless patients~ * Patients with drug or alcohol dependence~ * Children and neonates~ * Patients unable to participate in the consent process

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IV Injection of EC17 (Type: EXPERIMENTAL): The group will receive a single dose of EC17, infused over 10 minutes, prior to surgery. Then, during surgery, the EC-17 will be imaged with a camera that the investigators have developed.

Based on this trial design, predict the completion outcome and termination type (if applicable).